| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10026819 | Critical Reviews in Oncology/Hematology | 2018 | 45 Pages |
Abstract
The uptake of trastuzumab therapy varied widely between studies and across subgroups suggesting that there may be some inequalities in the use of this agent. However, our findings should be interpreted with caution due to study heterogeneity and potential confounding, and thus additional studies of individual level data which control for confounders are needed to understand more about inequalities in uptake.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Antony P. Martin, Jennifer Downing, Madeleine Cochrane, Brendan Collins, Ben Francis, Alan Haycox, Ana Alfirevic, Munir Pirmohamed,